SCHEMBL2959907

SCHEMBL2959907

CC1=CC(c2cccc3ccccc23)c2ccc(Br)cc21

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 3/20 0.39
MAPK1 P28482 2/20 0.39
ALDH1A1 P00352 4/20 0.35
HPGD P15428 3/20 0.35
NPSR1 Q6W5P4 2/20 0.35
KDM4E B2RXH2 1/20 0.35
TDP2 O95551 1/20 0.35
MAPT P10636 1/20 0.35
ALOX12 P18054 1/20 0.35
CASP3 P42574 1/20 0.35
HTT P42858 1/20 0.35
GALK1 P51570 1/20 0.35
BLM P54132 1/20 0.35
SENP8 Q96LD8 1/20 0.35
SENP7 Q9BQF6 1/20 0.35
SENP6 Q9GZR1 1/20 0.35
KDM4C Q9H3R0 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
KDM1A O60341 1/20 0.35
EGFR P00533 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2956770 0.90 CYP1A2 (0.35) CYP1A2MAPK1ALDH1A1HPGDNPSR1
SCHEMBL2975585 0.83 MAPK1 (0.41) CYP1A2MAPK1ALDH1A1HPGDMAPT
SCHEMBL2967043 0.79 MAPK1 (0.37) CYP1A2MAPK1ALDH1A1KDM4EEDNRB
SCHEMBL2962283 0.78 MAPK1 (0.39) CYP1A2MAPK1ALDH1A1KDM1AEDNRB
SCHEMBL2962768 0.78 CYP2A6 (0.44) CYP1A2MAPK1KDM4EKDM1AEGFR
SCHEMBL2975049 0.77 KDM4E (0.38) MAPK1ALDH1A1HPGDNPSR1KDM4E
SCHEMBL2959986 0.76 KDM1A (0.37) MAPK1ALDH1A1HPGDNPSR1KDM4E
SCHEMBL2973694 0.74 CYP1A2 (0.35) CYP1A2MAPK1MAPTHTTEDNRB
SCHEMBL2971514 0.72 ALDH1A1 (0.39) CYP1A2MAPK1ALDH1A1NPSR1KDM4E
SCHEMBL2963096 0.71 TP53 (0.35) CYP1A2MAPK1ALDH1A1MAPTSLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7763562-B2 Heteroatom bridged metallocene compounds for olefin polymerization EXXONMOBIL CHEMICAL PATENTS INC. (US) 2010-07-27 US disclosed
US-20070135597-A1 Heteroatom bridged metallocene compounds for olefin polymerization EXXONMOBIL CHEMICAL PATENTS INC. 2007-06-14 US disclosed
WO-2006065809-A2 HETEROATOM BRIDGED METALLOCENE COMPOUNDS FOR OLEFIN POLYMERIZATION EXXONMOBIL CHEMICAL PATENTS INC. (US) 2006-06-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070135597-A1 Heteroatom bridged metallocene compounds for olefin polymerization AP2M1, AP1M1, PYM1 CYP1A2 2409/4885MAPK1 3118/4885ALDH1A1 4332/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.